$2.65 $0.05 (1.9%)

11:10 AM EDT on 06/17/19

Stereotaxis Inc (NASDAQOTH:STXS)

CAPS Rating: No stars

The Company designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite, or cath lab.

Current Price $2.65 Mkt Cap $118.6M
Open $2.65 P/E Ratio 0.00
Prev. Close $2.60 Div. (Yield) $0.00 (0.0%)
Daily Range $2.65 - $2.68 Volume 3,500
52-Wk Range $1.07 - $2.90 Avg. Daily Vol. 1

Caps

How do you think NASDAQOTH:STXS will perform against the market?

Add Stock to CAPS Watchlist

All Players

135 Outperform
18 Underperform
 

All-Star Players

20 Outperform
8 Underperform
 

Wall Street

6 Outperform
1 Underperform
 

Top NASDAQOTH:STXS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

efti (66.26)
Submitted September 09, 2010

The data of the last comparative trial "At the European Cardiology Society Annual Congress in Stockholm last week, the research team led by Dr. Tamas Szili-Torok from the Erasmus Medical Center in Rotterdam presented the first comparative trial in a… More

jakeb24 (76.44)
Submitted August 08, 2011

BEsides the obvious numbers pointing to this stock's and possibly company's demise (Price to book 84x, earnings -.39, and huge amounts of debt), there are the real world applications of the companies products. After having talked to a few… More

NASDAQOTH:STXS VS S&P 500 (SPY)

Fools bullish on NASDAQOTH:STXS are also bullish on:

Fools bearish on NASDAQOTH:STXS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about STXS.

Recs

0
Member Avatar rhaltunen (< 20) Submitted: 1/17/2014 9:16:28 PM : Outperform Start Price: $5.57 NASDAQ OTHER:STXS Score: -109.47

I purchased this stock in 8/2013 based on technical analysis only. I noticed the large price and volume spike at the end of July. I waited a little too long to buy but still have a nice 8% gain. This was more of a speculative purchase than anything.

Recs

1
Member Avatar efti (66.26) Submitted: 9/9/2010 7:33:48 AM : Outperform Start Price: $39.80 NASDAQ OTHER:STXS Score: -253.14

The data of the last comparative trial
"At the European Cardiology Society Annual Congress in Stockholm last week, the research team led by Dr. Tamas Szili-Torok from the Erasmus Medical Center in Rotterdam presented the first comparative trial in a prospective study of 64 consecutive VT patients, comparing Stereotaxis VT ablation to conventional, non-magnetic ablation. Acute success was achieved in 97% of the Stereotaxis VT ablation group versus 81% of the manual ablation group. Patients in the Stereotaxis VT group averaged 50% less x-ray exposure, and after a year, only 14% VT recurrence, versus a 50% recurrence rate among manual ablation patients. A remarkable 25% reduction in total procedure time was achieved in the Stereotaxis VT group compared to the manual group.

There were no major complications in the Stereotaxis VT group compared to one death in the non-Stereotaxis group, representing a 4% major complication rate.

"The use of Stereotaxis offers major advantages for the ablation of VT," said Dr. Szili-Torok. "We have adopted a 100% utilization rule for our Stereotaxis lab for cardiac arrhythmias due to the significant benefits for our patients as well as for us as operators."
are impressive. If it was done fair they should explode.

Recs

0
Member Avatar 20100626 (29.85) Submitted: 7/17/2010 12:53:57 PM : Outperform Start Price: $36.30 NASDAQ OTHER:STXS Score: -263.67

Bravobevo

Leaderboard

Find the members with the highest scoring picks in STXS.

Score Leader

epc53

epc53 (27.88) Score: +373.62

The Score Leader is the player with the highest score across all their picks in STXS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
nicvo 97.47 2/2/2009 Underperform 5Y $25.50 -89.61% +260.81% +350.42 0 Comment
smithtz 84.29 2/4/2009 Underperform NS $28.30 -90.64% +250.19% +340.82 0 Comment
epc53 27.88 1/26/2009 Underperform NS $25.60 -89.65% +248.34% +337.99 0 Comment
anticitradeshort 32.15 4/20/2009 Underperform NS $33.20 -92.02% +242.64% +334.65 0 Comment
Maribaza 96.73 7/27/2010 Underperform 5Y $42.60 -93.78% +160.04% +253.82 1 Comment
BLOWKE 22.90 4/14/2008 Underperform 3W $61.10 -95.66% +126.28% +221.94 0 Comment
megatrade 62.00 3/3/2008 Underperform 3W $40.80 -93.50% +127.19% +220.69 0 Comment
ahknaten74 94.55 3/24/2008 Underperform NS $44.80 -94.08% +125.65% +219.73 0 Comment
dmclain2 < 20 3/26/2008 Underperform NS $56.80 -95.33% +123.72% +219.06 0 Comment
Calcio725 < 20 3/24/2008 Underperform 3W $56.30 -95.29% +121.88% +217.17 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCollinsStew 70.48 12/1/2010 Outperform NS $35.50 -92.54% +141.32% -233.86 0 Comment
TrackBreanMurray 45.79 6/3/2010 Outperform NS $37.70 -92.97% +162.15% -255.12 0 Comment
TrackOppenheimer 25.48 3/4/2010 Outperform NS $48.80 -66.39% +1.54% -67.93 8/9/2011 @ $16.40 0 Comment
TrackSoleil 93.92 10/6/2009 Outperform NS $44.50 -94.04% +176.86% -270.91 0 Comment
TrackJMP 82.80 4/10/2008 Outperform NS $74.80 -96.46% +121.22% -217.68 0 Comment
TrackBarrington 83.11 3/25/2008 Outperform NS $54.90 -95.17% +123.06% -218.24 0 Comment
TrackDeutscheSec 81.88 3/4/2008 Outperform NS $38.98 -93.20% +129.71% -222.91 0 Comment
TrackCollinsStew 70.48 1/16/2008 Outperform NS $89.60 -53.68% -27.01% -26.68 8/7/2009 @ $41.50 0 Comment
TrackNeedham 88.66 9/19/2007 Outperform NS $127.80 -70.11% -13.38% -56.73 3/31/2011 @ $38.20 0 Comment
TrackNextGen < 20 1/24/2007 Outperform NS $102.20 -95.98% -3.43% -92.55 4/17/2012 @ $4.11 0 Comment
TrackAGEdwards < 20 8/10/2006 Outperform NS $99.80 +21.54% +21.78% -0.24 6/1/2007 @ $121.30 0 Comment
TrackJimCramer 86.19 3/22/2006 Underperform 3W $136.40 -98.06% +138.17% +236.23 0 Comment

Advertisement